Biologicals for cancer treatment: monoclonal antibodies.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000096:biosynthesis / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D001402:B-Lymphocytes; D002986:Clinical Trials as Topic; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D007938:Leukemia / Q000276:immunology / Q000628:therapy; D007942:Leukemia, Experimental / Q000276:immunology / Q000628:therapy; D008223:Lymphoma / Q000276:immunology / Q000628:therapy; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D007130:Immunoglobulin Idiotypes